ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

NCT04203108 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

266

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: ATG
DRUG: CsA
DRUG: MTX
DRUG: MMF

Sponsor

Nanfang Hospital, Southern Medical University